{
  "id": "SCR-LIP-000771",
  "statement": "Lymphatic transport abnormalities are reported in many women with lipedema and are usually mild; whether they worsen with stage remains uncertain.",
  "claim_type": "clinical_association",
  "context": {
    "population": "lipedema patients, all clinical stages",
    "condition": "lipedema",
    "exposure": "lymphoscintigraphy assessment",
    "comparator": "—",
    "outcome": "prevalence and grade of lymphatic dysfunction",
    "scope": "auto-ingested from Layer 1 surveillance"
  },
  "knowledge_state": "emerging",
  "evidence_confidence": "moderate",
  "evidence": [
    {
      "ref": "DOI:10.1016/j.remn.2018.06.008",
      "stance": "supporting",
      "study_design": "cohort",
      "n": null,
      "risk_of_bias": "unknown",
      "year": 2018,
      "amato_authored": false,
      "note": "Prospective cohort of 83 patients with clinical lipedema undergoing lymphoscintigraphy; directly addresses lymphatic involvement in lipedema across stages, relevant to the question of progression to lymphedema and functional disability, tho",
      "title": "Hallazgos linfogammagráficos en pacientes con lipedema",
      "authors": "Forner-Cordero et al.",
      "journal": "Revista Española de Medicina Nuclear e Imagen Molecular",
      "grade": "moderate",
      "_prov": {
        "grade_source": "bib_curated"
      },
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "refines",
        "verdict": "verified",
        "reason": "The article directly reports 47% of lipedema patients had lymphoscintigraphic alterations across all clinical stages including stage 1, with low (35.9%) and low-moderate (48.7%) grades predominating and no severe cases, exactly matching the",
        "date": "2026-06-10"
      },
      "quote": "Lymphoscintigraphy showed alterations in 47% of the patients, most were low (35.9%) or low-moderate grade (48.7%). None of the patients were severely affected",
      "extraction_confidence": "moderate",
      "stance_in_source_claim": "refines",
      "finding": "In 83 patients, lymphoscintigraphic alterations in 47% across all stages including stage 1, mostly low or low-moderate grade, none severe.",
      "from_claims": [
        "SCR-LIP-000130"
      ]
    },
    {
      "ref": "DOI:10.1055/s-0039-1697904",
      "stance": "refines",
      "study_design": "cross_sectional",
      "n": null,
      "risk_of_bias": "unknown",
      "year": 2019,
      "amato_authored": false,
      "note": "This cross-sectional study directly addresses lymphatic dysfunction in lipedema and its association with clinical staging, providing objective lymphoscintigraphic evidence that lymphatic transport abnormalities worsen with lipedema severity",
      "title": "Uncovering Lymphatic Transport Abnormalities in Patients with Primary Lipedema",
      "authors": "Gould et al.",
      "journal": "Journal of Reconstructive Microsurgery",
      "grade": "moderate",
      "_prov": {
        "grade_source": "bib_curated"
      },
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "The article directly reports 63.2% of lower extremities with pathologic TI, mean TI 15.1 vs 9.7 for severe vs mild/moderate lipedema (p=0.049), and concludes impaired lymphatic transport is associated with greater severity — all matching th",
        "date": "2026-06-10"
      },
      "quote": "The mean TI was significantly greater for extremities with severe (stage 3/4) lipede",
      "extraction_confidence": "moderate",
      "stance_in_source_claim": "supporting",
      "finding": "Lymphoscintigraphy in 19 patients: pathologic transport (TI >10) in 63.2% of limbs; higher TI in stage 3/4 than stage 1/2 (15.1 vs 9.7, p=0.049).",
      "from_claims": [
        "SCR-LIP-000123"
      ]
    },
    {
      "ref": "DOI:10.23736/s0392-9590.21.04604-6",
      "stance": "supporting",
      "study_design": "review",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "very_low",
      "year": 2021,
      "amato_authored": false,
      "note": "The review addresses lymphatic dysfunction and clinical staging relevant to potential progression toward lymphedema, but as a narrative review it provides background/context rather than direct evidence quantifying progression to lymphedema ",
      "title": "Update in the management of lipedema",
      "authors": "FORNER-CORDERO et al.",
      "journal": "International Angiology",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "context",
        "verdict": "verified",
        "reason": "The article is a non-systematic review that describes lipedema's 4-stage classification, lymphatic dysfunction (abnormal lymphoscintigraphic patterns, impaired lymphatic transport, lymphatic aneurysmal structures), and cardiovascular/functi",
        "date": "2026-06-10"
      },
      "quote": "transporte linfático prejudicado em estágios precoces",
      "extraction_confidence": "moderate",
      "stance_in_source_claim": "context",
      "finding": "Review reports abnormal lymphoscintigraphic patterns and impaired lymphatic transport already in early stages, without quantifying progression to lymphedema.",
      "from_claims": [
        "SCR-LIP-000332"
      ]
    },
    {
      "ref": "DOI:10.3390/ijms23126621",
      "stance": "context",
      "study_design": "review",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "very_low",
      "year": 2022,
      "amato_authored": false,
      "note": "The review discusses mechanistic overlap and impaired lymphatic transport in lipedema, touching on the lipedema-lymphedema relationship, but frames it as a hypothesized/distinct pathophysiology rather than confirming clinical progression to",
      "title": "Current Mechanistic Understandings of Lymphedema and Lipedema: Tales of Fluid, Fat, and Fibrosis",
      "authors": "Duhon et al.",
      "journal": "International Journal of Molecular Sciences",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "refines",
        "verdict": "verified",
        "reason": "The abstract explicitly describes the trifecta framework with reverse temporal order (lipedema: fat→ECM/fibrosis→inflammation→fluid; lymphedema: fluid→inflammation→fibrosis→fat), confirms elevated VEGF-C and PF4 in lipedema, notes absence o",
        "date": "2026-06-10"
      },
      "quote": "Transporte linfático comprometido no lipedema (5 estudos citados) — evidência clínica de doença linfática",
      "extraction_confidence": "moderate",
      "stance_in_source_claim": "refines",
      "finding": "Review cites impaired lymphatic transport in lipedema but notes it lacks the T-cell inflammatory signature and lymphatic architectural changes of lymphedema, with fluid arising late.",
      "from_claims": [
        "SCR-LIP-000334"
      ]
    }
  ],
  "relations": [],
  "gaps": "",
  "curators": [],
  "created": "2026-11-20",
  "updated": "2026-11-20",
  "license": "CC-BY-4.0",
  "consolidated_from": [
    "SCR-LIP-000130",
    "SCR-LIP-000123",
    "SCR-LIP-000332",
    "SCR-LIP-000334"
  ],
  "questions_consolidated": [
    "SQ-LIP-000039"
  ],
  "provenance": {
    "method": "consolidation (R-CLM-19)",
    "store_key": "G-00217",
    "models": {
      "primary": "claude-opus-5.5 (Claude Code subagent, 1 repair round + arbitration)",
      "verifier": "claude-sonnet (Claude Code subagent, fresh context)",
      "mode": "agent"
    }
  },
  "history": [
    {
      "date": "2026-11-20",
      "event": "created_by_consolidation",
      "detail": "general proposition consolidated from SQ-LIP-000039"
    }
  ],
  "statement_pt": "Anormalidades do transporte linfático são relatadas em muitas mulheres com lipedema e geralmente são leves; permanece incerto se elas pioram com o estágio.",
  "answers_questions": [
    {
      "id": "SQ-LIP-000039",
      "role": "refines",
      "question": "Does lipedema progress to lymphedema (lipo-lymphedema)?",
      "url": "https://scientificclaims.org/q/SQ-LIP-000039.html"
    }
  ],
  "url": "https://scientificclaims.org/c/SCR-LIP-000771.html"
}